High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells

Virology

Volumn 228, Issue 2, 1997, Pages 285-293

  Clausse, Bernard ^a   Fizazi, Karim ^a   Walczak, Véronique ^a   Tetaud, Cécile ^a   Wiels, Joëlle ^a   Tursz, Thomas ^a   Busson, Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOID CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; VIRUS CELL INTERACTION;

HUMAN HERPESVIRUS 4;

EID: 0031575514     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8380     Document Type: Article

References (44)

1. Baichwal V. R., Sugden B. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene. 4:1989;67-74.
2. Brown D. A., Rose J. K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68:1992;533-544.
3. Busson P., Ganem G., Flores P., Mugneret F., Clausse B., Caillou B., Braham K., Wakasugi H., Lipinski M., Tursz T. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer. 42:1988;599-606.
4. Chang W. J., Ying Y. S., Rothberg K. G., Hooper N. M., Turner A. J., Gambliel H. A., De Gunzburg J., Mumby S. M., Gilman A. G., Anderson R. G. Purification and characterization of smooth muscle cell caveolae. J. Cell Biol. 126:1994;127-138.
5. Chun M., Liyanage U. K., Lisanti M. P., Lodish H. F. Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA. 91:1994;11728-11732.
6. Dawson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344:1990;777-780.
7. Deckert M., Ticchioni M., Bernard A. Endocytosis of GPI-anchored proteins in human lymphocytes: Role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J. Cell. Biol. 133:1996;791-799.
8. Delsol G., Brousset P., Chittal S., Rigual-Huguet F. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamH1-W probes in Hodgkin's disease. Am. J. Pathol. 140:1992;247-253.
9. Fahraeus R., Fu H. L., Ernberg I., Finke J., Rowe M., Klein G., Falk K., Nilsson E., Yadav M., Busson P., Tursz T., Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer. 42:1988;329-338.
10. Fra A. M., Williamson E., Simons K., Parton R. G. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J. Biol. Chem. 269:1994;30745-30748.
11. Fra A. M., Williamson E., Simons K., Parton R. G. De novo formation of caveolae in lymphocytes by expression of VIP21- caveolin. Proc. Natl. Acad. Sci. USA. 92:1995;8655-8659.
12. Gorodinsky A., Harris D. A. Glycolipid-anchored proteins in neuroblastoma cells form detergent- resistant complexes without caveolin. J. Cell Biol. 129:1995;619-627.
13. Hammarskjold M. L., Simurda M. C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol. 66:1992;6496-6501.
14. Hanada K., Nishijima M., Akamatsu Y., Pagano R. E. Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. J. Biol. Chem. 270:1995;6254-6260.
15. Hu L. F., Chen F., Zheng X., Ernberg I., Cao S. L., Christensson B., Klein G., Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene. 8:1993;1575-1583.
16. Huen D. S., Henderson S. A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
17. Kieff E. Fields Virology. 1996;Lippincott-Raven, Philadelphia/New York. p. 2343-2396.
18. Koleske A. J., Baltimore D., Lisanti M. P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92:1995;1381-1385.
19. Kurzchalia T. V., Hartmann E., Dupree P. Guilt by insolubility - Does a protein's detergent insolubility reflect a caveolar location? Trends Cell Biol. 5:1995;187-189.
20. Liebowitz D., Wang D., Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58:1986;233-237.
21. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell Biol. 7:1987;2299-2308.
22. Liebowitz D., Kieff E. Epstein-Barr virus latent membrane protein: Induction of B-cell activation antigens and membrane patch formation does not require vimentin. J. Virol. 63:1989;4051-4054.
23. Mann K. P., Staunton D., Thorley-Lawson D. A. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:1985;710-720.
24. Mann K. P., Thorley-Lawson D. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J. Virol. 61:1987;2100-2108.
25. Martin J., Sugden B. The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth. Differ. 2:1991a;653-660.
26. Martin J., Sugden B. Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J. Virol. 65:1991b;3246-3258.
27. Miller W. E., Earp H. S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:1995;4390-4398.
28. Mitchell T., Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:1995;2968-2976.
29. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
30. Murata M., Peranen J., Schreiner R., Wieland F., Kurzchalia T. V., Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA. 92:1995;10339-10343.
31. Nguer C. M., Pellegrini O., Galanaud P., Benveniste J., Thomas Y., Richard Y. Regulation of paf-acether receptor expression in human B cells. J. Immunol. 149:1992;2742-2748.
32. Paine E., Scheinman R. I., Baldwin A. S., Raab-Traub N. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins. J. Virol. 69:1995;4572-4576.
33. Parton R. G. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42:1994;155-166.
34. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333:1995;693-698.
35. Rickinson A. B., Kieff E. Fields B. N., Knipe D. M., Howley P. M., Chanock R. M., Melnick J. L., Monath T. P., Roizman B., Straus S. E. Fields Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia/New York.
36. Rothberg K. G., Heuser J. E., Donzell W. C., Ying Y. S., Glenney J. R., Anderson R. G. Caveolin, a protein component of caveolae membrane coats. Cell. 68:1992;673-682.
37. Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 68:1987;1575-1586.
38. Sargiacomo M., Sudol M., Tang Z., Lisanti M. P. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122:1993;789-807.
39. Scherer P. E., Okamoto T., Chun M., Nishimoto I., Lodish H. F., Lisanti M. P. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA. 93:1996;131-135.
40. Schnitzer J. E., McIntosh D. P., Dvorak A. M., Liu J., Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science. 269:1995;1435-1439.
41. Schroeder R., London E., Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc. Natl. Acad. Sci. USA. 91:1994;12130-12134.
42. Van Den Berg C. W., Cinek T., Hallett M. B., Horejsi V., Morgan B. P. Exogenous glycosyl phosphatidylinositol-anchored CD 59 associates with kinases in membrane clusters on U937 cells and becomes Ca+-signaling competent. J. Cell. Biol. 131:1995;669-677.
43. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:1985;831-840.
44. Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:1990;2309-2318.